Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 14, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Alcohol Use Disorder
Interventions
DRUG

Sunobinop

1 tablet taken orally at bedtime

DRUG

Placebo to match sunobinop

1 tablet taken orally at bedtime

Trial Locations (7)

11212

RECRUITING

Belmont Medical Office, Brooklyn

43212

RECRUITING

Ohio Clinical Trials, Columbus

77074

RECRUITING

Cebis Usa, Llc, Houston

77521

RECRUITING

Inquest Clinical Research, Baytown

010701

RECRUITING

Bio Terra Med SRL, Bucharest

010825

RECRUITING

"Spitalul Universitar De Urgenta Militar Central Dr. Carol Davila", Bucharest

050802

RECRUITING

Cabinet Medical Individual Dr. Andreea Popa, Bucharest

Sponsors
All Listed Sponsors
collaborator

Purdue Pharma LP

INDUSTRY

lead

Imbrium Therapeutics

INDUSTRY

NCT06545916 - Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder | Biotech Hunter | Biotech Hunter